510(k) Report

510(k) · Cleared

Cleared

Fiber Dust PRO

K220426510(k) SpecialCleared Mar 16, 202230-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quanta System Spa · GEX Powered Laser Surgical Instrument

Cleared on Mar 16, 2022 as substantially equivalent to K210142 (Quanta System Spa, 2021) after a 30-day review. Its family tree reaches back 1 generation to 2021.

Decided
Mar 16, 2022
Review
30 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K210142 (2021). No later device cites it as a predicate yet.

K210142 · Fiber Dust · Quanta System Spa · 2021202020222024
K210142 · Fiber Dust · Quanta System Spa · 20210
  1. Root · 1 generation backK210142 Fiber DustQuanta System Spa · 2021
  2. This deviceK220426 Fiber Dust PROQuanta System Spa · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K210142Fiber DustQuanta System Spa2021—
0 (this device)K220426Fiber Dust PROQuanta System Spa2022—
FIG. 1 — Lineage of K220426, 2021–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K210142Fiber Dust
Summary page 5
…GEX Basis for submission: Addition of a new model Predicate Device FiberDust – Quanta System S.p.A. (K210142) Description of the device: Fiber Dust PRO is a laser system that emits a wavelength of 1940 nm with a laser output power up to…
Quanta System Spa2021—

Also cleared against K210142: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K210142.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

Fiber Dust PRO is intended for incision, excision, resection, ablation, coagulation, hemostasis, and vaporization of soft tissue, with or without an endoscope, in the following indications: urology, lithotripsy, gastroenterological surgery and gynecological surgery. Urology * Ablation of Benign Prostatic Hyperplasia (Hypertrophy) [BPH] * Laser Resection of the Prostrate (LRP) * Laser Enucleation of the Prostate (LEP) * Laser Ablation of the Prostate…

Read the full statement (265 words)

Fiber Dust PRO is intended for incision, excision, resection, ablation, coagulation, hemostasis, and vaporization of soft tissue, with or without an endoscope, in the following indications: urology, lithotripsy, gastroenterological surgery and gynecological surgery.

Urology

* Ablation of Benign Prostatic Hyperplasia (Hypertrophy) [BPH]

* Laser Resection of the Prostrate (LRP)

* Laser Enucleation of the Prostate (LEP)

* Laser Ablation of the Prostate (LAP)

* Transurethral Incision of the Prostate (TUIP)

* Condylomas

* Urethral strictures

* Lesions of external genitalia

* Bladder neck incisions (BNI)

* Ablation and resection of bladder tumors, urethral tumors, and ureteral tumors

* Endoscopic fragmentation of urethral, ureteral, bladder, and renal calculi

* Treatment of distal impacted fragments remaining in the ureters following lithotripsy

Lithotripsy and Percutaneous Urinary Lithotripsy Indications

* Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate,

monohydrate and calcium oxalate dehydrate stones

* Endoscopic fragmentation of renal calculi

» Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed

Gastroenterology

Open and endoscopic gastroenterology surgery (incision, excision, resection, ablation, vaporization, coagulation and

haemostasis) including:

» Appendectomy

» Angiodysplasia

* Polyps

» Colorectal cancer

* Biopsy

» Telangiectasias

* Gall Bladder calculi

» Telangiectasias of the Osler-Weber-Renu disease

* Biliary/Bile duct calculi

* Vascular Malformation

* Ulcers

* Gastritis

* Gastric ulcers

* Esophagitis

* Duodenal ulcers

* Esophageal ulcers

* Non Bleeding Ulcers

* Varices

* Pancreatitis

* Colitis

» Haemorrhoids

» Mallory-Weiss tear

*Cholecystectomy

* Gastric Erosions

*Benign and Malignant Neoplasm

Gynecology

Open and laparoscopic gynecological surgery (incision, excision, resection, ablation, vaporization, coagulation and

hemostasis) of soft tissue.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K220426: Fiber Dust PRO.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K220426

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026